Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia
2
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Colesevelam
Research Leaders
5 sponsors active, led by Louisville VA Medical Center
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
50%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia
Research Network
Common Treatments
- Colesevelam1
- Sal003 140 Mg1
Active Sponsors
- Louisville VA Medical Center1
- University of Rhode Island1
- University of Louisville1
- Congressionally Directed Medical Research Programs1
- Shenzhen Salubris Pharmaceuticals Co., Ltd.1
Top Investigators
First Affiliated Hospital Xi'an Jiaotong University
The University of Rhode Island
Related Conditions
- Environmental Exposures1
- Hyperlipidemia Eg Hypercholesterolemia1
- Military Exposure1
- Occupational Exposure To Chemicals1
- Burn Pit Exposure1